94-32242. Determination of Regulatory Review Period for Purposes of Patent Extension; ZemuronSUPTM Injection; Correction  

  • [Federal Register Volume 60, Number 1 (Tuesday, January 3, 1995)]
    [Notices]
    [Pages 129-130]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 94-32242]
    
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    [Docket No. 94E-0234]
    
    
    Determination of Regulatory Review Period for Purposes of Patent 
    Extension; ZemuronTM Injection; Correction
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Notice; correction.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) is correcting the 
    notice that appeared in the Federal Register of September 15, 1994. The 
    document announced FDA's determination of the regulatory review period 
    for purposes of patent extension for ZeuronTM Injection 
    (rocuronium bromide). The document was published with some errors. The 
    document incorrectly stated: ``1. The date an exemption under section 
    505(i) of the Federal Food, Drug, and Cosmetic Act became effective: 
    January 15, 1994. The applicant claims January 14, 1989, as 
    [[Page 130]] the date the investigational new drug application (IND) 
    became effective. However, FDA records indicate that the IND effective 
    date was January 15, 1994, which was 30 days after FDA receipt of the 
    IND.'' The document should have stated: ``1. The date an exemption 
    under section 505(i) of the Federal Food, Drug, and Cosmetic Act became 
    effective: January 15, 1989. The applicant claims January 14, 1989, as 
    the date the investigational new drug application (IND) became 
    effective. However, FDA records indicate that the IND effective date 
    was January 15, 1989, which was 30 days after FDA receipt of the IND.'' 
    This document corrects those errors.
    
    FOR FURTHER INFORMATION CONTACT: Brian J. Malkin, Office of Health 
    Affairs (HFY-20), Food and Drug Administration, 5600 Fishers Lane, 
    Rockville, MD 20857, 301-443-1382.
    
        In FR Doc. 94-22760, appearing on page 47341 in the Federal 
    Register of September 15, 1994, the following corrections are made:
        On page 47341, in the second column, in the third paragraph, in the 
    fourth and ninth lines, ``January 15, 1994'' is corrected to read 
    ``January 15, 1989''.
    
        Dated: December 21, 1994.
    Stuart L. Nightingale,
    Associate Commissioner for Health Affairs.
    [FR Doc. 94-32242 Filed 12-30-94; 8:45 am]
    BILLING CODE 4160-01-F
    
    

Document Information

Published:
01/03/1995
Department:
Health and Human Services Department
Entry Type:
Notice
Action:
Notice; correction.
Document Number:
94-32242
Pages:
129-130 (2 pages)
Docket Numbers:
Docket No. 94E-0234
PDF File:
94-32242.pdf